Pulmonary Hypertension in Sickle Cell Disease -Study

Pulmonary hypertension (PH) is a complication of sickle cell disease. A study carried out to evaluate the prevalence of PH in patients with sickle cell disease.

Pulmonary hypertension, particularly pulmonary arterial hypertension (PAH), is often cited as a complication of sickle cell disease.

Characteristics of a classic case include the presence of pre-capillary pulmonary hypertension in the absence of left-sided heart disease, lung disease, or chronic thrombo embolism. Histopathology of small pulmonary arteries reveals proliferation of medial smooth-muscle cells and endothelial cells. In the updated classification of pulmonary hypertension, sickle cell disease (SCD) is included as a separate entity in the subgroup of PAH associated with identified diseases. Recent studies have revealed that the frequency of PAH in patients with SCD is 30%.

Heart Attack - Overview
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.

The objective of a study recently published in the New England Journal of Medicine was to evaluate the prevalence of pulmonary hypertension (PH) in adult patients with sickle cell disease (SCD) and confirm it with the help of right heart catheterization. In these patients, SCD was initially suspected on the basis of Doppler echocardiography.

Methods

In this prospective study, 398 outpatients (average age, 34 years) were recruited from referral centers for SCD in France. The study was also carried out in collaboration with the National Reference Center for Pulmonary Hypertension.

All patients included in the study were homozygous for hemoglobin S or had Sβ⁰ thalassemia. Only stable outpatients were included in the study.

Anemia | Low Hemoglobin (Haemoglobin) Causes Symptoms Diagnosis Treatment FAQs
Anemia is a condition in which the red blood cell (RBC) count or hemoglobin is less than normal.

Exclusion criteria included –

· Severe renal insufficiency,

Sickle Cell Anemia–Causes-Symptoms-Diagnosis-Treatment–Prognosis
Sickle cell anemia (SCA) is a genetic blood disorder caused by abnormal inherited hemoglobin. Sickle cell anemia is the most common form of sickle cell disease.

· Severe liver disease

· Chronic restrictive lung disease.

Animation of heart attack symptoms
Heart attack can cause symptoms such as Chest pain or discomfort, Shortness of breath and pain in neck, back, arm, or shoulder and is due to blockage of blood supply to the heart muscles

The patients were subjected to Doppler echocardiography, with measurement of tricuspid-valve regurgitant jet velocity. Right heart catheterization was performed in 96 patients in whom pulmonary hypertension was suspected.

Pulmonary hypertension was defined as a mean pulmonary arterial pressure of a minimum of 25 mm Hg.

Follow up was carried on for three years from date of study. Details of death, if any, were carefully documented.

Results & Conclusion

In this study of adult patients with sickle cell disease, the prevalence of a tricuspid regurgitant jet velocity, of at least 2.5 m per second, on echocardiography was 27%. This rate of occurrence was consistent with other studies carried out thus far.

In contrast, pulmonary hypertension prevalence that was confirmed on right heart catheterization was only about 6%. Approximately half of these patients, with confirmed PH, had pre-capillary pulmonary hypertension.

Based on their samples, the study concludes that the prevalence of pulmonary hypertension as detected on initial echocardiography screening, and confirmed by right heart catheterization, was 6% and that echocardiography alone was not enough to detect pulmonary hypertension.

Reference:

“A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease” Florence Parent, M.D., Dora Bachir, M.D., Jocelyn Inamo, M.D.,et al., N Engl J Med 2011; 365:44-53

Source-Medindia